APRI (aspartate aminotransferase [AST]-to-platelet ratio index) is recommended as the preferred non-invasive test (NIT) to assess for the presence of cirrhosis (APRI score >2 in adults) in resource-limited settings. Transient elastography (e.g. FibroScan) or FibroTest may be the preferred NITs in settings where they are available and cost is not a major constraint.

APRI Score Caculator

APRI Score = (AST/ULN) x 100) / platelet count (109/L)

Your ARPI Score :

Back to select


APRI score >2 in adults

Apri score > 2 has an 89% specificity in diagnosing cirrhosis. With a 35% sensitivity, an apri score cut off of > 2 could miss about two thirds with cirrhosis
(Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015, WHO).